Inactivation of the von Hippel–Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

Treatment of kidney cancer

(2010) William G. Kaelin   CANCER

Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma

(2010) Tricia M. Wright et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control

(2010) Juliette Gimenez et al.   NUCLEIC ACIDS RESEARCH

Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer

(2010) M.T. Romanish et al.   SEMINARS IN CANCER BIOLOGY

Hypoxia-inducible factor-2α mRNA expression in human renal cell carcinoma

(2009) Johanna Sandlund et al.   ACTA ONCOLOGICA

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

(2009) A. K. Ghosh et al.   BLOOD

Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements

(2009) Sebastian Szpakowski et al.   GENE

Endogenous retroviral LTRs as promoters for human genes: A critical assessment

(2009) Carla J. Cohen et al.   GENE

Serological Response to Human Endogenous Retrovirus K in Melanoma Patients Correlates with Survival Probability

(2008) Silvia Hahn et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients

(2008) F. Wang-Johanning et al.   CANCER RESEARCH

Endogenous retroviruses

(2008) K. Ruprecht et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

(2008) M. L. Nickerson et al.   CLINICAL CANCER RESEARCH

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

(2008) Yoshiyuki Takahashi et al.   JOURNAL OF CLINICAL INVESTIGATION

EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM

(2008) Francis C. Hsiao et al.   VIROLOGY